2013 Diabetes and Eye Disease Fact Sheet



Similar documents
2012 Georgia Diabetes Burden Report: An Overview

2005 Survey of Public Knowledge, Attitudes, and Practices Related to Eye Health and Disease. Executive Summary

Upstate New York adults with diagnosed type 1 and type 2 diabetes and estimated treatment costs

The State of Vision, Aging, and Public Health in America

Diabetes Brief. Pre diabetes occurs when glucose levels are elevated in the blood, but are not as high as someone who has diabetes.

Get Your Eyes Examined

Age-Related Eye Diseases and Conditions. See Well for a Lifetime

Texas Diabetes Fact Sheet

Kansas Behavioral Health Risk Bulletin

There may be no symptoms at first. Eye problems can. You can help prevent eye problems. Just because you have

Visual Disorders in Middle-Age and Elderly Patients with Diabetic Retinopathy

Connecticut Diabetes Statistics

Type 1 Diabetes ( Juvenile Diabetes)

Facts about Diabetes in Massachusetts

Shaping our future: a call to action to tackle the diabetes epidemic and reduce its economic impact

2005 Survey of Public Knowledge, Attitudes, and Practices Related to Eye Health and Disease

DEMONSTRATING MEANINGFUL USE STAGE 1 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EHR TECHNOLOGY IN 2015

DEMONSTRATING MEANINGFUL USE STAGE 1 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EHR TECHNOLOGY IN 2014

THE EYE INSTITUTE. Dear Patient:

Eye and Vision Care in the Patient-Centered Medical Home

Patient Demographic Sheet

Diabetes Complications

Eye Diseases , The Patient Education Institute, Inc. otf30101 Last reviewed: 05/21/2014 1

WELCOME TO COPPELL VISION CENTER

Diabetes: The Numbers

Diabetes. African Americans were disproportionately impacted by diabetes. Table 1 Diabetes deaths by race/ethnicity CHRONIC DISEASES

Assessing the Accuracy of the Technology-based Eye Care Services (TECS) Protocol to a Standard Clinical Ophthalmic Exam

Diabetes. Prevalence. in New York State

Medicare. Orientation Guide

Marketing Samples Medical Optometry

Alexandria Fairfax Sterling Leesburg

To help stay on schedule, keep your own written record of when you get the tests and exams. Include your goals and test results.

Post-Transplant Diabetes: What Every Patient Needs to Know

Guide to Eye Surgery and Eye-related Claims

TYPE 2 DIABETES IN THE AFRICAN AMERICAN COMMUNITY. Understanding the Complications That May Happen Without Proper Care

Vision Benefits for the way you Live, Work and Play

The Economic Benefit of Public Funding of Insulin Pumps in. New Brunswick

The Family Library. Understanding Diabetes

PREVALENCE OF VISUAL IMPAIRMENT AMONG DIABETIC PATIENTS IN THE KUMBA URBAN AREA, CAMEROON

Experience and Quality Assurance MES Vision Provider Network nationwide Four

Depression. Definition: Respondents who were told by a doctor, nurse, or health professional that they had some form of depression.

The Eye Care Center of New Jersey 108 Broughton Avenue Bloomfield, NJ 07003

PATIENT INFORMATION - Please complete and/or verify all information and make changes as necessary.

PATIENT REGISTRATION FORM PATIENT INFORMATION

FDA approves Lucentis (ranibizumab injection) for treatment of diabetic macular edema

DIABETES A chronic, debilitating and often deadly disease A global epidemic Diabetes in Africa

Visual Acuity, Impairments and Vision Insurance Plan Provisions. Stuart West Specialty Sales Manager Virginia CE Forum 2009 Course #

Welcome! Thank you for choosing our practice for your eye care needs! Please fill out our new patient registration paperwork.

BACKGROUND. ADA and the European Association recently issued a consensus algorithm for management of type 2 diabetes

TALLAHASSEE EYE CENTER

Which eye conditions can avastin injections be used for?

How We Make Sure You Get the Best Health Care

~Contributing to Eye Health~

National Diabetes Fact Sheet, 2011

Statistics of Type 2 Diabetes

Review of diabetes care in London Health and Environment Committee

CORONADO EYE ASSOCIATES GLENN B. COOK, M.D., PhD 801 ORANGE AVENUE, STE CORONADO, CA FAX

Diabetes and Obesity in Children. Janie Berquist, RN, BSN, MPH, CDE Children s Mercy Hospitals and Clinics Kansas City, MO

Retinal Consultants of San Antonio Diseases and Surgery of the Retina and Vitreous com

The Burden Of Diabetes And The Promise Of Biomedical Research

Diabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus

Treatment of diabetes In order to survive, people with type 1 diabetes must have insulin delivered by a pump or injections.

Preparing for laser treatment for diabetic retinopathy and maculopathy

THE EYE INSTITUTE. Eye Associates of Wayne P.A. 968 Hamburg Turnpike Wayne, NJ p f

Nutrition. Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT

Population Health Management Program

Avastin (Bevacizumab) Intravitreal Injection

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study

Lake Oswego Eye Clinic 530 First ST, Suite A Lake Oswego, OR Office: (503) Fax: (503)

19235 N Cave Creek Rd #104 Phoenix, AZ Phone: (602) Fax: (602)

Welcome to our Office!

NOTICE ABOUT REFRACTION

Type 2 Diabetes. Type 1 Diabetes. What is Diabetes? Diabetes during Pregnancy Very Thirsty Very Tired

MODERN CLINICAL OPTOMETRY BILLING & CODING THE MEDICAL EYE EXAMINATION. Definitions of Eye Examinations. Federal Government Definition

Monitoring Visual Outcomes of Cataract Surgery performed by a Non-physician Cataract Surgeon, at New Sight Eye Center, Paynesville City, Liberia

Diabetes & blindness. due to DME BLINDNESS IN EUROPE

Among all adults with diabetes, 92.0% have

Challenges in Glycemic Control in Adult and Geriatric Patients. Denyse Gallagher, APRN-BC, CDE Endocrinology Nurse Practitioner

Please allow us to welcome you to our practice. Our first priority is to provide you with the best care possible.

Preventing & Managing Complications of Diabetes

D I D Y O U K N O W? D I A B E T E S R E S O U R C E G U I D E. Blindness Heart Disease Strokes Kidney Failure Amputation

Vitreo-Retinal and Macular Degeneration Frequently Asked Questions

RHODE ISLAND SERVICES FOR THE BLIND AND VISUALLY IMPAIRED ORS/DHS THE INDEPENDENT LIVING FOR OLDER BLIND PROGRAM

WHAT IS A CATARACT, AND HOW IS IT TREATED?

Background (cont) World Health Organisation (WHO) and IDF predict that this number will increase to more than 1,3 million in the next 25 years.

Transcription:

The Georgia Department of Public Health 2013 Diabetes and Eye Disease Fact Sheet Diabetes is the leading cause of new cases of blindness among United States adults. 1-3 As Georgia s population ages and diabetes prevalence increases, eye disease will continue to be a major public health problem leading to blindness and reduced quality of life. Compared to adults without diabetes, adults with diabetes have a greater prevalence of many visual impairment-related diseases, including diabetic retinopathy, macular degeneration, cataracts, and glaucoma. 4 Diabetic retinopathy, characterized by the degradation of retinal blood vessels, has no warning and can interfere with living well. 5,6 Successfully managing glucose control and receiving a routine comprehensive dilated eye exam at least once a year can reduce the risk of eye disease by 54% to 76% and lead to the early detection of eye disease. 7,8 VISUAL IMPAIRMENT AMONG ADULT DIABETICS IN GEORGIA In 2010, among adult diabetics in Georgia, an estimated*: 9.1% (55,200 adults) were informed by an eye doctor or other healthcare professional that they had glaucoma 17.6% (107,700 adults) were informed by an eye doctor or other healthcare professional that they had cataracts 4.9% (30,000 adults) were informed by an eye doctor or other healthcare professional that they had age-related macular degeneration** In 2011, an estimated 20.6% of Georgia adult diabetics, or 154,500 persons, were told by a doctor that diabetes had affected their eyes or that they had retinopathy. The following Public Health Districts had the greatest prevalence of retinopathy during 2008-2010(Map 1): 3-3 (Clayton) at 24.7%, or 3,400 persons 3-4 (Lawrenceville) at 30.0%, or 14,500 persons 8-1 (Valdosta) at 28.2%, or 7,000 persons 8-2 (Albany) at 26.3%, or 9,300 persons Map 1. Prevalence of Retinopathy among Adult Georgia Diabetics by Health District, 2008-2010 *Data Source: Behavioral Risk Factor Surveillance System (2010) **Only adults 40 years of age or older 2 Peachtree Street, Atlanta, Ga 30303 health.state.ga.us March 2013

ANNUAL DILATED EYE EXAMS Many causes of visual impairment are readily diagnosed and at least 40% of blindness and visual impairment is treatable or preventable. 6,9 Due to the impact of eye disease on diabetics, Healthy People 2020 has the following objective: Increase the proportion of adults with diabetes who obtain an annual dilated eye examination. 10 Time since Last Dilated Eye Exam among Adult Diabetics in Georgia, 2011 Percent % (95% CI) Estimated Number of Diabetics Less than 1 year 66.5 (59.2, 73.2) 472,600 Between 1 and 2 years 17.1 (12.3, 23.3) 121,600 More than 2 years 16.3 (10.9, 23.7) 116,000 Data Source: Behavioral Risk Factor Surveillance System (2011) In 2011, the percentage of adult diabetics in Georgia who had a dilated eye examination (66.5%) within the previous 12 months was greater than the Healthy People 2020 target percentage of 58.7%. Geography The following Public Health Districts had the lowest prevalence of adult diabetics who had received a dilated eye exam in the previous 12 months: 5-1 (Dublin) at 50.5%, or 4,300 persons 1-2 (Dalton) at 64.2%, or 16,300 persons 9-2 (Waycross) at 65.0%, or 15,600 persons 5-2 (Macon) at 65.6%, or 24,200 persons 8-2 (Albany) at 67.6%, or 22,200 persons Map 2. Prevalence of Annual Dilated Eye Exam among Adult Georgia Diabetics by Health District, 2008-2010 The following Public Health Districts had the highest prevalence of adult diabetics who had received a dilated eye exam in the previous 12 months: 3-2 (Fulton) at 77.5%, or 29,000 persons 3-4 (Lawrenceville) at 82.3%, or 38,500 persons 3-5 (DeKalb) at 80.0%, or 26,000 persons 7 (Columbus) at 82.0%, or 23,800 persons

Time Trend Prevalence (%) Figure 1. Prevalence (%) of Annual Dilated Eye Exams among Georgia Adult Diabetics by Year, 2000 2010 80 68 71 72 70 71 69 69 60 40 20 74 74 70 71 0 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 Year Data Source: Behavioral Risk Factor Surveillance System (2000-2010) Between 2000 and 2010, the percentage of adult diabetics in Georgia who received an annual dilated eye exam did not increase significantly. (Figure 1) Demographics Figure 2. Prevalence (%) of Annual Dilated Eye Exams among Georgia Adult Diabetics by Demographics, 2011 Prevalence (%) 80 60 40 20 0 71 63 65 66 62 Male Female White, Non Hispanic Black, Non Hispanic 74 45 64 65+ Gender Race/Ethnicity Age Group* (years) Demographic *Sample size too small to provide reliable estimates for adults less than 45 years of age There were no significant differences in the prevalence of annual dilated eye exams among adult Georgia diabetics by gender, race/ethnicity, or age group. (Figure 2)

Prevalence (%) 80 60 40 20 Figure 3. Prevalence (%) of Annual Dilated Eye Exams among Georgia Adult Diabetics by Sociodemographic Measures, 2011 53 72 73 59 69 78 72 59 66 78 77 46 0 Less than High School High School Graduate Some college or more Less than $25,000 $25,000 $50,000 Greater than $50,000 Employed Out of Work Unable to Work Other** Any Health Coverage No Health Coverage Education Annual Income Employment Status* Insurance Status* Sociodemographic Measure *Data from 2009 and 2010 Behavioral Risk Factor Surveillance System **Other Employment Status includes homemakers, students, and retired individuals Data Source: Behavioral Risk Factor Surveillance System (2009, 2010, 2011) Adult diabetics that were high school graduates (71.7%; 151,700 persons) or had completed some college or more (73.4%; 202,000 persons) had a 35% and 38% greater prevalence, respectively, of having had an annual dilated eye exam than diabetics that had not graduated from high school. Compared to diabetics in households with annual incomes less than $25,000 (58.7%; 194,000 persons), diabetics in households with annual incomes greater than $50,000 (78.3%; 96,340 persons) had 33% greater prevalence of having had an annual dilated eye exam. Compared to diabetics out of work (58.7%; 22,500), employed diabetics (71.9%; 180,000) had 22% greater prevalence of having had an annual dilated eye exam. Adult diabetics in Georgia without health coverage (46%; 40,900 persons) had a 40% lower prevalence of having had an annual dilated eye exam than those with any health coverage (76.7%; 435,700 persons). (Figure 3)

BARRIERS TO RECEIVING EYE CARE Figure 4. Primary Reason for Not Visiting an Eye Care Professional in the Past 12 Months, Georgia Adult* Diabetics, 2010 2% 24% 34% Cost/Insurance Unable to get to office/clinic Unable to get an appointment No reason to go 7% 29% 1% 3% Have not thought of it Other Do not have/know an eye doctor *Only adults 40 years of age or older Data Source: Behavioral Risk Factor Surveillance System (2010) Among adult diabetics in Georgia, cost or insurance (34%; 58,000 persons) is the most cited reason for not visiting an eye care professional in the previous 12 months. 29% (48,000 persons) of Georgia adult diabetics stated that they had no reason to go to an eye care professional or did not have a problem. NATIONAL EYE DISEASE PREVENTION RECOMMENDATIONS Every percentage point decrease in A1c values can reduce the risk of diabetes related eye, kidney and nerve disease complications by 40%. 7 The development of severe vision loss due to diabetic eye disease can be reduced by an estimated 50% to 60% through scatter laser therapy. 1 o Laser therapy works best in the early stages of diabetic retinopathy o Annual dilated eye exams allow eye care professionals to detect diabetic retinopathy in the earlier stages 11 Appropriate eyeglasses may be able to help approximately 65% of adults with diabetes and poor vision. 1 The progression of diabetic retinopathy may be prevented through control of blood glucose, blood pressure, and blood cholesterol. 11

REFERENCES 1 Centers for Disease Control and Prevention, Division of Diabetes Translation, National Diabetes Fact Sheet, 2011 (Available at: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf) 2 National Institutes of Health, National Eye Institute: (Available at: http://www.nei.nih.gov/health/diabetic/retinopathy.asp ) 3 Kempen JH, O Colmain BJ, Leske MC, Haffner SM, Klein R, Moss SE, et al. The prevalence of diabetic retinopathy among adults in the United States. Archives of Ophthalmology. 2004, 122(4): 552-563. 4 Centers for Disease Control and Prevention, Division of Diabetes Translation, Vision Health Initiative (Available at: http://www.cdc.gov/visionhealth/data/national.htm ) 5 Institute of Medicine of the National Academies. Living Well with Chronic Illness: A Call For Public Health Action. Committee on Living Well with Chronic Disease: Public Health Action to Reduce Disability and Improve Functioning and Quality of Life. (Available at: http://www.nap.edu/catalog.php?record_id=13272 ) 6 Prevent Blindness America and National Eye Institute, Vision Problems in the U.S.: Prevalence of Adult Vision Impairment and Age-Related Eye Disease in America Report. 2012. (Available at: www.visionproblemsus.org ) 7 American Diabetes Association. Standards of Medical Care in Diabetes. 2012. (Available at: http://care.diabetesjournals.org/content/35/supplement_1/s11.full.pdf+html ) 8 Diabetes Control and Complications Trial (DCCT). The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin- Dependent Diabetes Mellitus. New England Journal of Medicine, 329(14), September 30, 1993. (Results available here: http://diabetes.niddk.nih.gov/dm/pubs/control/dcct- EDIC_508.pdf ) 9 Congdon N, O Colmain B, Klaver CCW, Klein R, Muñoz B, Friedman D, et al. Causes and prevalence of visual impairment among adults in the United States. Archives of Ophthalmology. 2004; 122: 477-485. 10 U.S. Department of Health and Human Services, Healthy People 2020. (Available at: http://www.healthypeople.gov/2020/topicsobjectives2020/default.aspx ) 11 National Institutes of Health, National Eye Institute: (Available at: http://www.nei.nih.gov/health/diabetic/diabeticretino.pdf )